Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects

By Chunxiao Li, P. Jiang, Shuhua Wei, Xiaofei Xu, Junjie Wang. Molecular Cancer, 2020

773 citations recorded by the source corpus.

Regulatory T cells (Tregs) characterized by the expression of the master transcription factor forkhead box protein p3 (Foxp3) suppress anticancer immunity, thereby hindering protective immunosurveillance of tumours and hampering effective antitumour immune responses in tumour-bearing hosts, constitute a current research hotspot in the field. However, Tregs are also essential for the maintenance of the immune tolerance of the body and share many molecular signalling pathways with conventional T cells, including cytotoxic T cells, the primary mediators of tumour immunity. Hence, the inability to specifically target and neutralize Tregs in the tumour microenvironment without globally compromising self-tolerance poses a significant challenge. Here, we review recent advances in characterizing tumour-infiltrating Tregs with a focus on the functional roles of costimulatory and inhibitory receptors in Tregs, evaluate their potential as clinical targets, and systematically summarize their roles in potential treatment strategies. Also, we propose modalities to integrate our increasing knowledge on Tregs phenotype and function for the rational design of checkpoint inhibitor-based combination therapies. Finally, we propose possible treatment strategies that can be used to develop Treg-targeted therapies.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/4e326622563fca5fa81fa7d87a1cb479dfb83820

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Y. Shiravand
  2. R. Ladwa
  3. K. O'Byrne
  4. S. R. Hosseini-Fard
  5. Faezeh Khodadadi
  6. Seyyed Mohammad Amin Kashani
  7. H. Sadeghirad
  8. Shadi Hosseini

Citations in the corpus